18 May 2019

Conditions

‘Slow medicine’ is changing the game

7 May 2019

Conditions Pharmacy Guild of Australia

Cost barrier to new GCA drug may be lifted

6 May 2019

Conditions Patient Perspective

What is Sjögren’s syndrome and who gets it?

6 May 2019

Conditions

Off to your first international conference? Here are some tips

23 April 2019

Analgesics Conditions

What to expect from this year’s flu season

16 April 2019

Ankylosing Spondylitis Biologics EULAR

Game-changing RA drugs out of Third World’s reach

16 April 2019

Ankylosing Spondylitis Biologics

Biosimilar launch will make affordable rituximab a reality

12 April 2019

Analgesics Conditions EULAR Spondyloarthritis

APLAR interviews: RA treatment in 2030

10 April 2019

Conditions Obesity

Collective effort to fight growing obesity

10 April 2019

Conditions EULAR

APLAR interviews: Takayasu arteritis

10 April 2019

EULAR Spondyloarthritis

The hunt for the perfect predictor

28 March 2019

Analgesics Biologics Conditions Corticosteroids Spondyloarthritis

Take only as directed: high-dose Xeljanz poses PE risk

25 March 2019

Conditions Women

Better pregnancy outcomes for IBD patients

18 March 2019

Conditions Spondyloarthritis

No benefit in regular MRIs for RA

18 March 2019

Conditions Scleroderma

Study loosens links between secukinumab and IBD

18 March 2019

Analgesics Conditions Polymyalgia Rheumatica

The mysterious connection between sleep apnoea and gout